These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38815910)

  • 1. Effectiveness and Safety of Early Versus Routine Switching from Low-Molecular-Weight Heparin to Maintenance Therapy of Rivaroxaban for Acute Iliofemoral Vein Thrombosis: A Retrospective Cohort Study.
    Hou W; Fang D; Yin S; Deng Y; Zhang J; Wang S; Liu L; Kong J; Huang M; Zhang X; Dai B; Feng X
    Ann Vasc Surg; 2024 Sep; 106():152-161. PubMed ID: 38815910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of acute Deep Vein Thrombosis in pediatric and adolescent orthopedic trauma hospitalized patients and effect of rivaroxaban treatment.
    Hou W; Kong J; Liu L; Han Y; Ren F; Yin S; Huang M; Deng Y; Zhang J; Dai B; Feng X
    Injury; 2024 Aug; 55(8):111710. PubMed ID: 38976928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recanalization of lower-limb deep veins as an index of efficacy of treatment for acute venous thrombosis].
    Kuznetsov MR; Sapelkin SV; Boldin BV; Leont'ev SG; Neskhodimov LA
    Angiol Sosud Khir; 2016; 22(3):82-8. PubMed ID: 27626254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban after Thrombolysis in Acute Iliofemoral Venous Thrombosis: A Randomized, Open-labeled, Multicenter Trial.
    Kang JM; Park KH; Ahn S; Cho S; Han A; Lee T; Jung IM; Kim JY; Min SK
    Sci Rep; 2019 Dec; 9(1):20356. PubMed ID: 31889152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of safety and efficacy comparison of low molecular heparin calcium sequential oral anticoagulants in the treatment of cirrhotic portal vein thrombosis.
    Zhang J; Dang X; Zhang L; Li W
    Eur J Gastroenterol Hepatol; 2024 Sep; 36(9):1119-1125. PubMed ID: 39101441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of rivaroxaban versus low-molecular-weight heparin therapy in patients with lower limb fractures.
    Long A; Zhang L; Zhang Y; Jiang B; Mao Z; Li H; Zhang S; Xie Z; Tang P
    J Thromb Thrombolysis; 2014 Oct; 38(3):299-305. PubMed ID: 24402194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Novel Oral Anticoagulants vs Low Molecular Weight Heparin for Thromboprophylaxis in Large-Volume Liposuction and Body Contouring Procedures.
    Morales R; Ruff E; Patronella C; Mentz H; Newall G; Hustak KL; Fortes P; Bush A
    Aesthet Surg J; 2016 Apr; 36(4):440-9. PubMed ID: 26961988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD005259. PubMed ID: 35993965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.
    Turpie AGG; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Ageno W
    Thromb Res; 2017 Jul; 155():23-27. PubMed ID: 28477534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Safety and Efficacy of Rivaroxaban with Warfarin for Patients after Successful Stent Placement for Chronic Iliofemoral Occlusion: A Retrospective Single Institution Study.
    Zhang X; Huang J; Peng Z; Lu X; Yang X; Ye K
    Eur J Vasc Endovasc Surg; 2021 Mar; 61(3):484-489. PubMed ID: 33388238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban.
    Houghton DE; Casanegra AI; Peterson LG; Cochuyt J; Hodge DO; Vlazny D; McBane RD; Froehling D; Wysokinski WE
    Am J Hematol; 2020 Jul; 95(7):817-823. PubMed ID: 32267011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
    Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
    Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center.
    Hays K; Jolly M; Silver M; Phillips J; Huff C; Secic M; Ansel G; Kolluri R
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):753-759.e1. PubMed ID: 32827732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.